AMKbiotech
Aïda Meghraoui is the Founder & CEO of AMKbiotech. Prior to starting their own company, Aïda worked as a Senior Scientist at IPMC CNRS-U. NICE SOPHIA, focusing on the project "Characterization of cutaneous squamous cell carcinoma tumor microenvironment using multiparametric mass imaging." Aïda also collaborated with Inserm, Vanderbilt University Medical Center, and Institut Pasteur on various projects. Aïda holds a PhD in Immunology from Université de Reims Champagne-Ardenne and has a background in Parasitology, Environmental Sciences, and Pharmacy.
This person is not in any teams
AMKbiotech
AMKbiotech provides the biomedical research actors with a specialized expertise and tailored services in biomarker identification and drug efficacy evaluation using Spatial Biology and High-Plex Cytometry analysis. From project design to computational AI-based data analysis, our end-to-end services aim to accelerate translational, pre-clinical studies. If you want to use * spatial biology approach * or * advanced cytometry * in your project, contact us, we take care of all the steps from the study design to the data analysis : https://www.amkbiotech.fr/